Analystreport

Fulcrum Therapeutics, Inc. (NASDAQ: FULC) had its price target lowered by analysts at Stifel Nicolaus from $43.00 to $35.00.

Fulcrum Therapeutics, Inc.  (FULC) 
Last fulcrum therapeutics, inc. earnings: 3/5 07:00 am Check Earnings Report